Form 4 · Filed Jun 10, 2026, 12:32 AM UTC
ABEO/ABEONA THERAPEUTICS INC.
Vasanthavada Madhav — Chief Commercial Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
2 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 9, 2026 | S | sell | 5,450 | $5 | $28,908 | 303,451 |
| Jun 8, 2026 | S | sell | 4,170 | $5 | $22,641 | 308,901 |
Source: SEC EDGAR raw filing ↗ · Accession 0001493152-26-028021